Study,Study Country,Study Site,Subject,Event Group Label,Event Group Name,Event Group Sequence Number,Event Label,Event Name,Event Date,Form Casebook Version,Form Label,Form Name,Form Sequence Number,Form Status,Datetime of Form Creation,Form First Submission Date,Form Last Submission Date,Form ILB Status,Form ILB Reason,Item Group Sequence Number,Datetime of Last Data Change,Data Listing As Of,Opened Queries,Closed Queries,Collection date & time (ig_AESILB.LBDTC_2),Collection date & time (ig_AESILB.LBDTC_2)_UTC,Collection date & time (ig_AESILB.LBDTC_2)_USER,Collection date & time (ig_AESILB.LBDTC_2)_RAW,Specimen type (ig_AESILB.LBSPEC),Lab test (ig_AESILB.LBCTEST),Result (ig_AESILB.LBORRES),Lower normal range symbol (ig_AESILB.LBCORNRL_SYMBOL),Lower normal range (ig_AESILB.LBCORNRL_VALUE),Upper normal range symbol (ig_AESILB.LBCORNRH_SYMBOL),Upper normal range (ig_AESILB.LBCORNRH_VALUE),Units (ig_AESILB.LBCRESU),Form SDV Status,Form SDV Datetime,Form DMR Status,Form DMR Datetime,Form Frozen Status,Form Frozen Datetime,Form Locked Status,Form Locked Datetime,Form Signed Status,Form Signed Datetime,LINKEDTO
M24-977_TST1,United States,9999999,SCR-0257,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,1,Submitted,2024-12-30 06:54:05 UTC,,2024-12-30 07:23:22 UTC,false,,1,2024-12-30 06:55:03 UTC,2025-08-19 10:50:46 UTC,0,0,2024-05-01 11:34:00 EDT,2024-05-01 15:34:00 UTC,2024-05-01 15:34:00 GMT,01-May-2024 11:34,Adipose Tissue,"1,25-Dihydroxycalciferol; 1,25-Dihydroxyergocalciferol; 1,25-Dihydroxyvitamin D2; Ercalcitriol",47,>=,56,<,34,% INHIBITION,No,,No,,No,,No,,No,,"1 Form(s):Infusion-Related Reaction Adverse Event - Supplemental [FA_LB_IAE] (#1) -- Symptom = CHILLS/RIGORS, Other , Specify = , Onset date and time of symptom = 01-Oct-2024 11:32"
M24-977_TST1,United States,9999998,SCR-0025,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,2,Submitted,2024-11-11 13:03:20 UTC,,2024-11-11 13:09:20 UTC,false,,1,2024-11-11 13:09:18 UTC,2025-08-19 10:50:46 UTC,9,1,2023-11-14 11:00:00 EST,2023-11-14 16:00:00 UTC,2023-11-14 16:00:00 GMT,14-Nov-2023 11:00,,,,,,,,,No,,No,,No,,No,,No,,
M24-977_TST1,United States,9999998,SCR-0025,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,3,Submitted,2024-11-11 13:19:42 UTC,,2024-11-11 13:25:57 UTC,false,,1,2024-11-11 13:25:55 UTC,2025-08-19 10:50:46 UTC,8,1,2023-08-16 11:00:00 EDT,2023-08-16 15:00:00 UTC,2023-08-16 15:00:00 GMT,16-Aug-2023 11:00,,,,,,,,,No,,No,,No,,No,,No,,
M24-977_TST1,United States,9999998,SCR-0025,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,1,Submitted,2024-11-11 12:37:00 UTC,,2024-11-11 12:51:44 UTC,false,,1,2024-11-11 12:51:41 UTC,2025-08-19 10:50:46 UTC,8,3,2023-06-25 11:00:00 EDT,2023-06-25 15:00:00 UTC,2023-06-25 15:00:00 GMT,25-Jun-2023 11:00,,,,,,,,,No,,No,,No,,No,,No,,
M24-977_TST1,United States,9999999,SCR-0009,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,3,Submitted,2024-11-19 10:24:13 UTC,,2024-11-19 10:24:43 UTC,false,,1,2024-11-19 10:24:42 UTC,2025-08-19 10:50:46 UTC,1,0,2024-11-13 12:14:00 EST,2024-11-13 17:14:00 UTC,2024-11-13 17:14:00 GMT,13-Nov-2024 12:14,Abscess fluid,"1,25-Di(OH)vitamin D2 + 1,25-Di(OH)vitamin D3; 1,25-Dihydroxyvitamin D2 + 1,25-Dihydroxyvitamin D3; 1,25-DihydroxyvitD2+1,25-DihydroxyvitD3",123,>=,123,<=,345,%(v/v),No,,No,,No,,No,,No,,
M24-977_TST1,United States,9999999,SCR-0017,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,1,Submitted,2024-11-19 11:48:06 UTC,,2024-11-19 11:51:20 UTC,false,,1,2024-11-19 11:49:06 UTC,2025-08-19 10:50:46 UTC,1,0,2033-03-21 17:48:00 EDT,2033-03-21 21:48:00 UTC,2033-03-21 21:48:00 GMT,21-Mar-2033 17:48,Mucus,AB-FUBINACA,Resultaaaaaaaaaaaa_1,>,93,<,46,fmol/g,No,,No,,No,,No,,No,,"1 Form(s):Hepatic Adverse Event Supplemental [FA_PR_LO] (#1) -- Is the subject currently symptomatic? = Y, Hepatic involvement of disease under study = Y, Drug or alcohol abuse = Y"
M24-977_TST1,United States,9999999,SCR-0017,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,2,Submitted,2024-11-19 11:48:13 UTC,,2024-11-19 11:51:26 UTC,false,,1,2024-11-19 11:49:36 UTC,2025-08-19 10:50:46 UTC,1,0,2033-03-26 17:48:00 EDT,2033-03-26 21:48:00 UTC,2033-03-26 21:48:00 GMT,26-Mar-2033 17:48,Blood,HCT Corrected Reticulocytes/Erythrocytes,Resultaaaaaaaaaaaa_1,>=,17,<=,87,log10 TCID 50/dose,No,,No,,No,,No,,No,,"1 Form(s):Hepatic Adverse Event Supplemental [FA_PR_LO] (#1) -- Is the subject currently symptomatic? = Y, Hepatic involvement of disease under study = Y, Drug or alcohol abuse = Y"
M24-977_TST1,United States,9999999,SCR-0009,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,1,Submitted,2024-11-19 10:19:54 UTC,,2024-11-19 10:21:47 UTC,false,,1,2024-11-19 10:21:39 UTC,2025-08-19 10:50:46 UTC,0,1,2024-11-04 12:31:00 EST,2024-11-04 17:31:00 UTC,2024-11-04 17:31:00 GMT,04-Nov-2024 12:31,Bone marrow mononuclear cell,"1,25-Dihydroxycalciferol; 1,25-Dihydroxyergocalciferol; 1,25-Dihydroxyvitamin D2; Ercalcitriol",123456789,>,123456789,<,324234233,% INHIBITION,No,,No,,No,,No,,No,,
M24-977_TST1,United States,9999999,SCR-0017,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,3,Submitted,2024-11-19 11:48:21 UTC,,2024-11-19 11:51:33 UTC,false,,1,2024-11-19 11:50:08 UTC,2025-08-19 10:50:46 UTC,1,0,2033-03-31 17:48:00 EDT,2033-03-31 21:48:00 UTC,2033-03-31 21:48:00 GMT,31-Mar-2033 17:48,Calculus,Lymphoblasts; Lymphoid Blasts,Resultaaaaaaaaaaaa_1,>=,15,<=,32,ug/L FEU,No,,No,,No,,No,,No,,"1 Form(s):Hepatic Adverse Event Supplemental [FA_PR_LO] (#1) -- Is the subject currently symptomatic? = Y, Hepatic involvement of disease under study = Y, Drug or alcohol abuse = Y"
M24-977_TST1,United States,9999999,SCR-0009,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,4,In Progress,2024-11-19 10:25:51 UTC,,,false,,1,2024-11-19 10:26:19 UTC,2025-08-19 10:50:46 UTC,0,0,2024-11-16 11:11:00 EST,2024-11-16 16:11:00 UTC,2024-11-16 16:11:00 GMT,16-Nov-2024 11:11,Alveolar air,"1,5-Anhydroglucitol",12,>,,,,,No,,No,,No,,No,,No,,
M24-977_TST1,United States,9999998,SCR-0029,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,1,Submitted,2024-11-11 14:43:16 UTC,,2024-11-11 14:46:37 UTC,false,,1,2024-11-11 14:46:34 UTC,2025-08-19 10:50:46 UTC,10,1,2025-04-03 17:00:00 EDT,2025-04-03 21:00:00 UTC,2025-04-03 21:00:00 GMT,03-Apr-2025 17:00,,,,,,,,,No,,No,,No,,No,,No,,
M24-977_TST1,United States,9999999,SCR-0009,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,2,Submitted,2024-11-19 10:22:16 UTC,,2024-11-19 10:23:35 UTC,false,,1,2024-11-19 10:23:34 UTC,2025-08-19 10:50:46 UTC,3,0,2024-11-18 12:12:00 EST,2024-11-18 17:12:00 UTC,2024-11-18 17:12:00 GMT,18-Nov-2024 12:12,Peripheral blood mononuclear cell,"1,25-Dihydroxycalciferol; 1,25-Dihydroxyergocalciferol; 1,25-Dihydroxyvitamin D2; Ercalcitriol",123,,12,,345,%,No,,No,,No,,No,,No,,
M24-977_TST1,United States,9999999,SCR-0017,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,4,Submitted,2024-11-19 11:48:28 UTC,,2024-11-19 11:51:38 UTC,false,,1,2024-11-19 11:50:39 UTC,2025-08-19 10:50:46 UTC,1,0,2033-04-05 17:48:00 EDT,2033-04-05 21:48:00 UTC,2033-04-05 21:48:00 GMT,05-Apr-2033 17:48,Menstrual blood,Amyloid Beta 1-38; Amyloid Beta 38; Amyloid Beta 38 Protein,Resultaaaaaaaaaaaa_1,>=,41,<=,82,nmol BCE/mmol,No,,No,,No,,No,,No,,
M24-977_TST1,United States,9999999,SCR-0017,Common Forms,eg_COMMON,1,Common,ev_COMMON,,1,Adverse Event Supplemental Labs,AESI_LB,5,Submitted,2024-11-19 11:48:35 UTC,,2024-11-19 11:51:44 UTC,false,,1,2024-11-19 11:51:11 UTC,2025-08-19 10:50:46 UTC,1,0,2033-04-10 17:48:00 EDT,2033-04-10 21:48:00 UTC,2033-04-10 21:48:00 GMT,10-Apr-2033 17:48,Skin tissue,N-Acetyl Glucosamide/Creatinine,Resultaaaaaaaaaaaa_1,>,84,<,78,pmol/10^9 cells,No,,No,,No,,No,,No,,
